BRIACELL THERAPEUTICS CORP. Payments of Stock Issuance Costs
BRIACELL THERAPEUTICS CORP. (BCTX) reported Payments of Stock Issuance Costs of $57.12 thousand for the 12-month period ending 2022-07-31, per its 10-K filed 2023-10-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-10-25
- BRIACELL THERAPEUTICS CORP. payments of stock issuance costs for fiscal 2022 was $57.12K.
| Period end | Payments of Stock Issuance Costs 12 month |
|---|---|
| 2022-07-31 | $57.12K 10-K · filed 2023-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |